21-46126476-T-TGGCCCGGCCCGGCCCGGCCC
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_001849.4(COL6A2):c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00878 in 1,610,762 control chromosomes in the GnomAD database, including 91 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0057 ( 6 hom., cov: 32)
Exomes 𝑓: 0.0091 ( 85 hom. )
Consequence
COL6A2
NM_001849.4 intron
NM_001849.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.874
Genes affected
COL6A2 (HGNC:2212): (collagen type VI alpha 2 chain) This gene encodes one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The product of this gene contains several domains similar to von Willebrand Factor type A domains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in this gene are associated with Bethlem myopathy and Ullrich scleroatonic muscular dystrophy. Three transcript variants have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 21-46126476-T-TGGCCCGGCCCGGCCCGGCCC is Benign according to our data. Variant chr21-46126476-T-TGGCCCGGCCCGGCCCGGCCC is described in ClinVar as [Likely_benign]. Clinvar id is 420369.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAd4 at 6 AD,AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL6A2 | NM_001849.4 | c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC | intron_variant | ENST00000300527.9 | NP_001840.3 | |||
COL6A2 | NM_058174.3 | c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC | intron_variant | NP_478054.2 | ||||
COL6A2 | NM_058175.3 | c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC | intron_variant | NP_478055.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL6A2 | ENST00000300527.9 | c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC | intron_variant | 1 | NM_001849.4 | ENSP00000300527.4 | ||||
COL6A2 | ENST00000397763.6 | c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC | intron_variant | 5 | ENSP00000380870.1 | |||||
COL6A2 | ENST00000409416.6 | c.2423-18_2423-17insCGGCCCGGCCCGGCCCGGCC | intron_variant | 5 | ENSP00000387115.1 |
Frequencies
GnomAD3 genomes AF: 0.00567 AC: 862AN: 152116Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
862
AN:
152116
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00910 AC: 13274AN: 1458528Hom.: 85 Cov.: 34 AF XY: 0.00876 AC XY: 6358AN XY: 725706
GnomAD4 exome
AF:
AC:
13274
AN:
1458528
Hom.:
Cov.:
34
AF XY:
AC XY:
6358
AN XY:
725706
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00566 AC: 862AN: 152234Hom.: 6 Cov.: 32 AF XY: 0.00535 AC XY: 398AN XY: 74434
GnomAD4 genome
AF:
AC:
862
AN:
152234
Hom.:
Cov.:
32
AF XY:
AC XY:
398
AN XY:
74434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2017 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | COL6A2: BS1, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at